PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-Oct-2025 MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions ACCESS Newswire
23-Oct-2025 Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma Heidelberg Pharma
23-Oct-2025 Tezspire approved in the EU for chronic rhinosinusitis with nasal polyps AstraZeneca, Amgen
23-Oct-2025 Oncopeptides to host Capital Markets Update featuring leading global experts in Multiple Myeloma Oncopeptides
23-Oct-2025 Novo Nordisk board changes: expert comment Novo Nordisk, University of Bath
23-Oct-2025 Medivir enters exclusive licensing agreement with Biossil, Inc. for remetinostat Medivir
23-Oct-2025 Groundbreaking new projects launched to lower the cost of monoclonal antibody production LifeArc
23-Oct-2025 HUTCHMED Highlights HMPL-A251 Data Presented at the AACR NCI EORTC International Conference on Molecular Targets and Cancer Therapeutics HUTCHMED
23-Oct-2025 Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey Sanofi, Medidata
23-Oct-2025 ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market ACCESS Newswire
23-Oct-2025 Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP ACCESS Newswire
23-Oct-2025 VSee Health Strengthens Balance Sheet With The Elimination of Debt ACCESS Newswire
23-Oct-2025 Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence ACCESS Newswire
23-Oct-2025 NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies NRG Therapeutics
23-Oct-2025 NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies NRG Therapeutics
23-Oct-2025 Cantargia to Participate in Upcoming Conferences ACCESS Newswire
23-Oct-2025 Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo ACCESS Newswire
23-Oct-2025 BHL Removers debuts at Lab Innovations 2025 BHL Removers
23-Oct-2025 Moderna to Host Investor Event - Analyst Day ACCESS Newswire
23-Oct-2025 maxon presents precision drive system engineering at Lab Innovations maxon UK & Ireland